大灣區聚變力量(01189.HK):暫停獨立非執行董事溫冠麟的職責及權力
格隆匯7月4日丨大灣區聚變力量(01189.HK)發佈公告,獨立非執行董事溫冠麟先生(“溫先生”)已連續超過六個月缺席董事會及董事委員會的所有會議,亦未與公司聯絡。儘管公司曾多次嘗試聯絡溫先生,但溫先生一直無故缺乏聯絡。有鑑於此,董事會認爲溫先生無法履行其作爲獨立非執行董事的職責。董事會已議決即時暫停溫先生的所有職責及權力。
獨立非執行董事溫先生並無參與集團業務及營運的日常管理。董事會認爲,暫停彼的職責及權力並不會對集團的業務及營運造成任何影響。公司股份已自2024年4月2日起在聯交所暫停買賣,並將繼續暫停買賣,直至另行通知爲止。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.